BA
AMGN icon

Bennicas & Associates’s Amgen AMGN Stock Holding History

Bennicas & Associates’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$3.13M Sell
11,905
-150
-1% -$40.2K 1.81% 13
2022
Q3 		$2.72M Sell
12,055
-150
-1% -$36.4K 1.73% 12
2022
Q2 		$2.97M Sell
12,205
-110
-0.9% -$27K 1.73% 12
2022
Q1 		$2.98M Sell
12,315
-200
-2% -$46K 1.5% 17
2021
Q4 		$2.81M Buy
12,515
+1,695
+16% +$358K 1.46% 16
2021
Q3 		$2.3M Hold
10,820
– – 1.29% 23
2021
Q2 		$2.64M Hold
10,820
– – 1.45% 18
2021
Q1 		$2.69M Sell
10,820
-650
-6% -$155K 1.55% 15
2020
Q4 		$2.64M Buy
+11,470
New +$2.64M 1.54% 18

Other funds holding AMGN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bennicas & Associates's AMGN Position: Q4 2022 in Review

Bennicas & Associates reduced its Amgen (AMGN) stake by 1.2% in Q4 2022, selling an estimated $40.2K and leaving 11,905 shares worth $3.13M. The position accounts for 1.81% of the portfolio, ranked #13.

Bennicas & Associates first reported a position in AMGN in Q4 2020 and has held it in 9 quarters since. 2,501 funds tracked by Wall St. Rank hold AMGN as of Q4 2022.

  • Bennicas & Associates held 11,905 shares of Amgen worth $3.13M as of Q4 2022.
  • Bennicas & Associates sold 150 Amgen shares in Q4 2022, an estimated $40.2K.
  • Amgen made up 1.81% of Bennicas & Associates's portfolio in Q4 2022, its #13 holding.
  • Bennicas & Associates first reported a position in Amgen in Q4 2020 and has held it in 9 quarters since.
  • 2,501 funds tracked by Wall St. Rank held Amgen as of Q4 2022.

Based on Bennicas & Associates's 13F filing for Q4 2022, filed 12 Jan 2023.